Isomerase Therapeutics

Technology Development

Isomerase is investing significant time and resource to continue developing and in-licensing new cutting-edge technologies in the microbial natural products field. These are enabling more rapid and efficient generation of diversity from microbial systems, more efficient selection of products capable of binding to and inhibiting targets of interest and more efficient and rapid generation of cost-efficient routes to production of natural products.

We strongly believe that these technologies have the potential to help bring in a new era of cost efficient and rapid discovery and development of natural products across a wide variety of industries and therapeutic areas.